Literature DB >> 18289702

Lentivirus-induced immune dysregulation.

Mary B Tompkins1, Wayne A Tompkins.   

Abstract

FIV/HIV infections are associated with an early robust humoral and cellular anti-viral immune response followed by a progressive immune suppression that eventually results in AIDS. Several mechanisms responsible for this immune dysfunction have been proposed including cytokine dysregulation, immunologic anergy and apoptosis, and inappropriate activation of immune regulatory cells. Studies on FIV infection provide evidence for all three. Cytokine alterations include decreases in IL2 and IL12 production and increases in IFNgamma and IL10 in FIV(+) cats compared to normal cats. The elevated IL10:IL12 ratio is associated with the inability of FIV(+) cats to mount a successful immune response to secondary pathogens. Additionally, chronic antigenic (FIV) stimulation results in an increase in the percent of activated T cells expressing B7 and CTLA4 co-stimulatory molecules in infected cats. The expression of these molecules is associated with T cells that are undergoing apoptosis in the lymph nodes. As ligation of CTLA4 by B7 transduces a signal for induction of anergy, one can speculate that the activated T cells are capable of T cell-T cell interactions resulting in anergy and apoptosis. The inability of CD4(+) cells from FIV(+) cats to produce IL2 in response to recall antigens and the gradual loss of CD4(+) cell numbers could be due to B7-CTLA4 interactions. The chronic antigenemia may also lead to activation of CD4(+)CD25(+) T regulatory cells. Treg cells from FIV(+) cats are chronically activated and inhibit the mitogen-induced proliferative response of CD4(+)CD25(-) by down-regulating IL2 production. Although Treg cell activation can be antigen-specific, the suppressor function is not, and thus activated Treg cells would suppress responses to secondary pathogens as well as to FIV. Concomitant with the well-known virus-induced immune suppression is a progressive immune hyper-activation. Evidence for immune hyper-activation includes polyclonal B cell responses, gradual replacement of naïve CD4(+) and CD8(+) T cell phenotypes with activation phenotypes (CD62L(-), B7(+), CTLA4(+)), and the chronic activation of CD4(+)CD25(+) Treg cells. Thus lentivirus infections lead to severe immune dysregulation manifested as both chronic immune suppression and chronic immune activation. FIV infection of cats provides a number of advantages over other lentivirus infections as a model to study this immune dysregulation. It is a natural infection that has existed in balance with the cat's immune system for thousands of years. As such, the natural history and pathogenesis provides an excellent model to study the long-term relationships between AIDS lentivirus and host immune system function/dysregulation.

Entities:  

Mesh:

Year:  2008        PMID: 18289702      PMCID: PMC2410212          DOI: 10.1016/j.vetimm.2008.01.011

Source DB:  PubMed          Journal:  Vet Immunol Immunopathol        ISSN: 0165-2427            Impact factor:   2.046


  84 in total

1.  Detection of three distinct patterns of T helper cell dysfunction in asymptomatic, human immunodeficiency virus-seropositive patients. Independence of CD4+ cell numbers and clinical staging.

Authors:  M Clerici; N I Stocks; R A Zajac; R N Boswell; D R Lucey; C S Via; G M Shearer
Journal:  J Clin Invest       Date:  1989-12       Impact factor: 14.808

2.  Evidence for type 2 cytokine production and lymphocyte activation in the early phases of HIV-1 infection.

Authors:  L Meroni; D Trabattoni; C Balotta; C Riva; A Gori; M Moroni; M Luisa Villa; M Clerici; M Galli
Journal:  AIDS       Date:  1996-01       Impact factor: 4.177

3.  Molecularly cloned feline immunodeficiency virus NCSU1 JSY3 induces immunodeficiency in specific-pathogen-free cats.

Authors:  J S Yang; R V English; J W Ritchey; M G Davidson; T Wasmoen; J K Levy; D H Gebhard; M B Tompkins; W A Tompkins
Journal:  J Virol       Date:  1996-05       Impact factor: 5.103

Review 4.  AIDS as immune system activation. II. The panergic imnesia hypothesis.

Authors:  M S Ascher; H W Sheppard
Journal:  J Acquir Immune Defic Syndr (1988)       Date:  1990

5.  Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases.

Authors:  S Sakaguchi; N Sakaguchi; M Asano; M Itoh; M Toda
Journal:  J Immunol       Date:  1995-08-01       Impact factor: 5.422

6.  Cytokine production by cats infected with feline immunodeficiency virus: a longitudinal study.

Authors:  C E Lawrence; J J Callanan; B J Willett; O Jarrett
Journal:  Immunology       Date:  1995-08       Impact factor: 7.397

7.  Apoptosis occurs predominantly in bystander cells and not in productively infected cells of HIV- and SIV-infected lymph nodes.

Authors:  T H Finkel; G Tudor-Williams; N K Banda; M F Cotton; T Curiel; C Monks; T W Baba; R M Ruprecht; A Kupfer
Journal:  Nat Med       Date:  1995-02       Impact factor: 53.440

8.  Pathogenesis of experimentally induced feline immunodeficiency virus infection in cats.

Authors:  J K Yamamoto; E Sparger; E W Ho; P R Andersen; T P O'Connor; C P Mandell; L Lowenstine; R Munn; N C Pedersen
Journal:  Am J Vet Res       Date:  1988-08       Impact factor: 1.156

9.  Analysis of apoptosis in lymph nodes of HIV-infected persons. Intensity of apoptosis correlates with the general state of activation of the lymphoid tissue and not with stage of disease or viral burden.

Authors:  C A Muro-Cacho; G Pantaleo; A S Fauci
Journal:  J Immunol       Date:  1995-05-15       Impact factor: 5.422

10.  Feline immunodeficiency virus (FIV)-specific cytotoxic T lymphocytes from chronically infected cats are induced in vitro by retroviral vector-transduced feline T cells expressing the FIV capsid protein.

Authors:  W Song; E W Collisson; J Li; A M Wolf; J H Elder; C K Grant; W C Brown
Journal:  Virology       Date:  1995-06-01       Impact factor: 3.616

View more
  18 in total

1.  Expression of regulatory T cell (Treg) activation markers in endometrial tissues from early and late pregnancy in the feline immunodeficiency virus (FIV)-infected cat.

Authors:  N N Lockett; V L Scott; C E Boudreaux; B T Clay; S B Pruett; P L Ryan; K S Coats
Journal:  Placenta       Date:  2010-08-02       Impact factor: 3.481

2.  Effect of Chuanminshen violaceum polysaccharides and its sulfated derivatives on immunosuppression induced by cyclophosphamide in mice.

Authors:  Xinghong Zhao; Yuetian Zhang; Xu Song; Zhongqiong Yin; Renyong Jia; Xingfang Zhao; Xin Lai; Guangxi Wang; Xiaoxia Liang; Changliang He; Lizi Yin; Cheng Lv; Ling Zhao; Gang Shu; Gang Ye; Fei Shi
Journal:  Int J Clin Exp Med       Date:  2015-01-15

3.  Domain- and nucleotide-specific Rev response element regulation of feline immunodeficiency virus production.

Authors:  Hong Na; Willem Huisman; Kristofor K Ellestad; Tom R Phillips; Christopher Power
Journal:  Virology       Date:  2010-06-08       Impact factor: 3.616

4.  CD4(+)CD25(+) T regulatory cells inhibit CD8(+) IFN-gamma production during acute and chronic FIV infection utilizing a membrane TGF-beta-dependent mechanism.

Authors:  Jonathan E Fogle; Angela M Mexas; Wayne A Tompkins; Mary B Tompkins
Journal:  AIDS Res Hum Retroviruses       Date:  2010-02       Impact factor: 2.205

5.  Prior mucosal exposure to heterologous cells alters the pathogenesis of cell-associated mucosal feline immunodeficiency virus challenge.

Authors:  Surender B Kumar; Sarah Leavell; Kyle Porter; Barnabe D Assogba; Mary J Burkhard
Journal:  Retrovirology       Date:  2010-05-28       Impact factor: 4.602

Review 6.  Placental immunopathology in the FIV-infected cat: a role for inflammation in compromised pregnancy?

Authors:  Karen S Coats; Crystal E Boudreaux; Brittany T Clay; Nikki N Lockett; Veronica L Scott
Journal:  Vet Immunol Immunopathol       Date:  2009-10-14       Impact factor: 2.046

Review 7.  The role of BST2/tetherin in feline retrovirus infection.

Authors:  Isabelle Dietrich; Margaret J Hosie; Brian J Willett
Journal:  Vet Immunol Immunopathol       Date:  2011-06-12       Impact factor: 2.046

8.  Anti-Inflammatory Therapy for Feline Immunodeficiency Virus Infection and Associated AIDS-Like Syndrome.

Authors:  Arne Lucas Ten Hoeve; Arden Leander van Arnhem
Journal:  Front Microbiol       Date:  2011-07-19       Impact factor: 5.640

9.  Diversity of trends of viremia and T-cell markers in experimental acute feline immunodeficiency virus infection.

Authors:  Sylvain Roche; Hanane El Garch; Sylvie Brunet; Hervé Poulet; Jean Iwaz; René Ecochard; Philippe Vanhems
Journal:  PLoS One       Date:  2013-02-07       Impact factor: 3.240

Review 10.  Recent developments in human immunodeficiency virus-1 latency research.

Authors:  Chi Ngai Chan; Isabelle Dietrich; Margaret J Hosie; Brian J Willett
Journal:  J Gen Virol       Date:  2013-01-30       Impact factor: 3.891

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.